賽諾醫療(688108.SH):新一代HT Infinity藥物洗脱支架系統獲得醫療器械變更註冊批准
格隆匯6月1日丨賽諾醫療(688108.SH)公佈,近日,公司收到國家藥品監督管理局頒發的公司新一代HT Infinity藥物洗脱支架系統的《醫療器械變更註冊文件》。
公司新一代HT Infinity藥物洗脱支架系統增加4.5-5.0mm規格在國家藥監局獲批上市,標誌着公司4.5~5.0mm直徑10-30mm長度的產品可以進入國內市場銷售,有效填補了國內該類產品的空白,將進一步提升公司冠脈支架產品在市場上的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.